Back

Cannabis and Microbiome: A Systematic Review and Meta-Analysis.

Thu, M. S.; Ondee, T.; Hall, S. R.; Nopsopon, T.; Jagota, A.; Hirankarn, N.; Pongpirul, K.

2023-01-03 addiction medicine
10.1101/2022.12.31.22284080
Show abstract

BackgroundWith cannabis legalization spreading to more countries for both medicinal and recreational use, grasping its effects on the human body is vital. The endocannabinoid system, governed by natural and external cannabinoid compounds, significantly impacts host metabolism. Working alongside the hosts immunomodulation, it shapes the gut microbiota, yielding benefits for the GI and immune systems. ObjectiveTo assess the link between cannabis treatment and the gut/oral microbiome. MethodsWe extensively searched PubMed, Embase, and Cochrane Librarys CENTRAL until December 9, 2023, for English studies involving adults with clinical abnormalities. Identified studies were analyzed, categorizing by different clinical aspects. Data was then qualitatively and quantitatively synthesized. ResultThe study involved 10 studies encompassing 2511 participants, comprising 2 clinical trials and 8 observational studies. The review provided a range of microbiota by the influence of cannabis usage within different clinical contexts: HIV infection, pain/inflammation, systemic aspergillosis, obesity, cognitive deficits, and oral diseases. Users with anhedonia and HIV infection showed lower -diversity, but those with knee arthritis showed higher -diversity. According to research, 21.4% of MJ cigarette users experienced adverse outcomes; however, these lessened once they stopped smoking. ConclusionThese findings shed light on the complex effects of cannabis use on the human microbiota, underscoring the need for future research on the therapeutic potential of cannabis. This review provides valuable insights to guide future investigations in this field. Registration IDPROSPERO 2022 CRD42022354331 Short SummaryWith the global expansion of cannabis legalization, understanding the effects of cannabis on the human body, particularly among individuals with diverse clinical conditions, is of paramount importance. Through a meticulous systematic review utilizing comprehensive data, our findings uncover that cannabis consumption in adults with varied clinical conditions leads to discernable alterations in the human microbiome. These noteworthy modifications necessitate careful consideration in future investigations exploring the potential beneficial or adverse effects of cannabis treatment on patients.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Addiction Biology
based on 13 papers
Top 0.1%
16.0%
2
Translational Psychiatry
based on 94 papers
Top 1%
11.7%
3
Drug and Alcohol Dependence
based on 21 papers
Top 0.5%
5.3%
4
International Journal of Drug Policy
based on 11 papers
Top 0.3%
4.7%
5
Frontiers in Immunology
based on 140 papers
Top 2%
4.7%
6
Neuropsychopharmacology
based on 29 papers
Top 0.6%
4.7%
7
PLOS ONE
based on 1737 papers
Top 71%
4.7%
50% of probability mass above
8
Frontiers in Psychiatry
based on 56 papers
Top 3%
2.9%
9
Scientific Reports
based on 701 papers
Top 52%
2.9%
10
American Journal of Psychiatry
based on 14 papers
Top 0.2%
2.9%
11
Neuroscience & Biobehavioral Reviews
based on 19 papers
Top 0.7%
2.6%
12
Molecular Psychiatry
based on 84 papers
Top 3%
2.5%
13
Brain Stimulation
based on 27 papers
Top 1%
2.5%
14
Addiction
based on 24 papers
Top 1%
2.4%
15
Cerebral Cortex
based on 15 papers
Top 0.4%
1.6%
16
JAMA Network Open
based on 125 papers
Top 10%
1.6%
17
Progress in Neuro-Psychopharmacology and Biological Psychiatry
based on 10 papers
Top 0.2%
1.6%
18
Biological Psychiatry
based on 36 papers
Top 3%
1.6%
19
International Journal of Environmental Research and Public Health
based on 116 papers
Top 16%
1.4%
20
Human Brain Mapping
based on 53 papers
Top 5%
1.2%
21
Clinical Epigenetics
based on 21 papers
Top 1%
1.2%
22
Spatial and Spatio-temporal Epidemiology
based on 10 papers
Top 0.8%
0.8%
23
The British Journal of Psychiatry
based on 21 papers
Top 3%
0.8%
24
Clinical Pharmacology & Therapeutics
based on 19 papers
Top 1%
0.8%
25
BMJ Open
based on 553 papers
Top 49%
0.8%
26
Frontiers in Genetics
based on 32 papers
Top 5%
0.8%
27
JMIR Research Protocols
based on 18 papers
Top 3%
0.8%
28
Brain Sciences
based on 19 papers
Top 2%
0.7%
29
European Journal of Neuroscience
based on 10 papers
Top 0.7%
0.7%